Characteristic peptides of phospholipase A2 from Agkistrodon acutus and their application

Through liquid chromatography-mass spectrometry detection of the A2 characteristic polypeptide group of phospholipase A2, the problem of complex detection methods and low sensitivity in the prior art was solved, and the species identification with high sensitivity was achieved, and the hemagglutinin drug was improved. Supported by quality control and phospholipase A2 pharmacological research.

CN116217666BActive Publication Date: 2024-12-03SHANDONG INST FOR FOOD & DRUG CONTROL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310433239.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-21
Publication Date
2024-12-03
Estimated Expiration
2043-04-21

AI Technical Summary

Technical Problem

In the prior art, the detection method of phospholipase A2 of the genus viper is complex and has low sensitivity, making it difficult to effectively identify its genera sources, affecting the quality control and pharmacological research of hemagglutinin drugs.

Method used

The characteristic polypeptide group of phospholipase A2 was detected by electrospray positive ion mode through liquid chromatography-mass spectrometer to identify characteristic polypeptide 1 (WDIYPYSWK) and characteristic polypeptide 2 (DNLDTYNSDTYWR) to determine the phospholipase A2 in the sample. Gene source.

Benefits of technology

It has achieved high sensitivity and accuracy in the identification of phospholipase A2 genera, significantly improved the quality control level of hemagglutinin drugs, ensured the effectiveness and safety of the product, and supported more pharmacological treatments of phospholipase A2. Development of academic activity and clinical application.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116217666B_ABST
    Figure CN116217666B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of chemical analysis qualitative detection, and in particular to a group of characteristic polypeptides of Agkistrodon acutus phospholipase A2 and applications thereof. The characteristic polypeptide group consists of characteristic polypeptide 1 and characteristic polypeptide 2, and the specific amino acid sequence is: the amino acid sequence of characteristic polypeptide 1 is WDIYPYSWK, and the amino acid sequence of characteristic polypeptide 2 is DNLDTYNSDTYWR. The characteristic polypeptide group can be used to detect the species source of the characteristic polypeptide of Agkistrodon acutus phospholipase A2 in the sample to be tested, and the detection accuracy is high, which can significantly improve the quality control level of Agkistrodon acutus hemocoagulase, and ensure the effectiveness and safety of the product clinical medication. On the other hand, it also provides a guarantee for the development of more pharmacological activities and clinical applications of Agkistrodon acutus phospholipase A2.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of chemical analysis qualitative detection, in particular to a characteristic polypeptide group of Agkistrodon acutus phospholipase A2 and an application thereof. Background Art

[0002] Snake venom phospholipase A2 (PLA2) is one of the most abundant enzymes in snake venom glands. According to the "target site and action site" theory, PLA2 from different species has different structures, different modes of action, and exhibits different pharmacological activities. For example, presynaptic neurotoxins may be related to the hydrophobic region between residues 80 and 110 on PLA2; the hydrophobic E helix of PLA2 with muscle toxin activity contains a specific oxygen ion region; the residue region 54-77 is related to the anticoagulant activity, and the lysine of PLA2 with strong anticoagulant activity is replaced by neutral or acidic amino acids, while this phenomenon does not occur in PLA2 without anticoagulant activity.

[0003] Studies have shown that phospholipase A2 from Agkistrodon acutus inhibits ADP-induced platelet aggregation and catalyzes the hydrolysis of the ester bond at the 2-position of sn-3-phosphoglyceride to generate free fatty acids and lysophospholipids. Agkistrodon acutus hemocoagulase is a hemostatic drug and is widely used in clinical hemostasis. As a potential impurity, phospholipase A2 has the potential to cause neurotoxicity, myotoxicity, cardiotoxicity, and some side effects such as convulsions, hypotension, and edema. Therefore, it is very important to control the phospholipase in hemocoagulase preparations. In the current standard, phospholipase A2 uses UV-visible spectrophotometry, which is complicated to operate and has low sensitivity. Therefore, whether as a new anti-inflammatory drug with research value or as an impurity in Agkistrodon acutus hemocoagulase, it is very important to develop a simple and fast method with species identification for the study of Agkistrodon acutus phospholipase A2 and the quality control of Agkistrodon acutus hemocoagulase drugs. Summary of the invention

[0004] To solve the above technical problems, the purpose of the present invention is to provide a characteristic polypeptide group of phospholipase A2 of Agkistrodon acutus, which can play an important role in characterizing the species source of phospholipase A2 of Agkistrodon acutus in samples, filling the gap in species identification of phospholipase A2 of Agkistrodon acutus.

[0005] In order to achieve the above-mentioned invention object, the present invention adopts the following technical solutions:

[0006] A characteristic polypeptide group of Agkistrodon acutus phospholipase A2, which consists of a characteristic polypeptide 1 and a characteristic polypeptide 2; wherein the amino acid sequence of the characteristic polypeptide 1 is WDIYPYSWK, and the amino acid sequence of the characteristic polypeptide 2 is DNLDTYNSDTYWR.

[0007] An application of the above-mentioned characteristic polypeptide group of Agkistrodon acutus phospholipase A2, wherein the characteristic polypeptide group can be used to identify the species source of Agkistrodon acutus phospholipase A2.

[0008] Furthermore, the above application adopts the following identification steps:

[0009] (1) Dissolve the sample to be tested and inactivate it by enzymatic hydrolysis to prepare the test solution;

[0010] (2) Water was treated with enzymes to prepare a blank solution;

[0011] (3) injecting the test solution prepared in step (1) and the blank solution prepared in step (2) into a liquid chromatography-mass spectrometer, and performing multiple reaction monitoring in electrospray positive ion mode, using mass-to-charge ratios of m / z 629.30→302.11 and 629.30→680.34 as detection ion pairs of characteristic polypeptide 1, and using mass-to-charge ratios of m / z 831.86→230.08 and 831.86→941.41 as detection ion pairs of characteristic polypeptide 2, so as to determine whether the sample to be tested contains characteristic polypeptide 1 and characteristic polypeptide 2 in the characteristic polypeptide of phospholipase A2 of Agkistrodon acutus;

[0012] (4) If both characteristic polypeptide 1 and characteristic polypeptide 2 are detected at the same time, it proves that the sample to be tested contains phospholipase A2 and is derived from Agkistrodon acutus; otherwise, it proves that the sample to be tested does not contain phospholipase A2 from Agkistrodon acutus.

[0013] Preferably, in the liquid chromatography-mass spectrometer of step (3), the liquid phase conditions and mass spectrometry detection conditions are: Waters ACQUITY UPLC BEH C 18 Chromatographic column (50 mm*2.1 mm, 1.7 μm); mobile phase A: 0.1% formic acid solution mobile phase, B: 0.1% formic acid acetonitrile; column temperature: 40°C; injection volume: 2 μL; flow rate: 0.3 ml / min; gradient elution according to the table below:

[0014]

[0015] Preferably, the specific operation of step (2) is:

[0016] ① Dissolution of the sample to be tested: The sample to be tested is prepared with 25 mM ammonium bicarbonate to a concentration of 1 µg / µL;

[0017] ② Enzymatic hydrolysis: Take 100 µL of the sample dissolved in step ①, add 1 µg of protease and hydrolyze at 37℃ overnight, and inactivate at high temperature after the hydrolysis is completed;

[0018] ③ Centrifugation: Finally, take the sample inactivated by enzymatic hydrolysis in step ②, centrifuge it at 12000 rpm for 10 min, and take the supernatant to obtain the sample to be tested.

[0019] Preferably, the protease is trypsin.

[0020] Compared with the prior art, the present invention has the following beneficial effects: since the amino acid sequences of phospholipase A2 of snake venoms such as Agkistrodon acutus, Agkistrodon lancehead, and Agkistrodon rotundus are known to not contain the characteristic polypeptide group described in the present invention, the characteristic polypeptide group can be used to detect the species source of the characteristic polypeptide of Agkistrodon acutus phospholipase A2 in the sample to be tested, and the detection accuracy is high. On the one hand, it fills the gap in the quality standard of Agkistrodon acutus hemocoagulase, and can significantly improve the quality control level of Agkistrodon acutus hemocoagulase, ensuring the effectiveness and safety of the product in clinical use; on the other hand, it also provides a guarantee for the development of more pharmacological activities and clinical applications of phospholipase A2. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. The embodiments of the present invention are described in detail below in conjunction with the accompanying drawings, wherein:

[0022] Figure 1 This is the secondary mass spectrum of the characteristic polypeptide 1 WDIYPYSWK of the phospholipase A2 of Agkistrodon acutus in Example 1;

[0023] Figure 2 The secondary mass spectrum of the characteristic polypeptide 2 DNLDTYNSDTYWR of the phospholipase A2 of Agkistrodon acutus in Example 1;

[0024] Figure 3 The extracted ion chromatogram of the characteristic polypeptide of Vipera venom in Example 2;

[0025] Figure 4 The ion chromatogram of the characteristic polypeptide extracted from the venom of Agkistrodon acutus in Example 2; Implementation

[0026] The following description further describes the specific details of the present invention for a full understanding of the present invention. The terms used in the description of the present invention are only used to illustrate the advantages and features of the present invention and are not intended to limit the present invention.

[0027] Unless otherwise defined, all professional and scientific terms used in the present invention have the same meanings as those understood by technicians in the technical field of the present invention. Unless otherwise specified, the drugs or reagents used in the present invention are used in accordance with the product instructions or the conventional methods of use in the field. The technical solution of the present invention is further described according to the drawings and specific embodiments of the specification. Example 1

[0028] Screening and identification of characteristic peptides of phospholipase A2 from Agkistrodon acutus

[0029] (1) Reagents and consumables

[0030] Reagents: formic acid, acetonitrile, iodoacetamide, trypsin (Sigma), guanidine hydrochloride (VETEC,, dithiothreitol (BBI Life Sciences), and other reagents were of analytical grade.

[0031] Instruments: ultrapure water instrument (Milli_Q), electronic balance (METTLERTOLEDO), freeze dryer (LABCONC), centrifugal concentrator (LABCONC), high-resolution mass spectrometer (Thermo Scientific, QEplus), nanoliter liquid phase system (ThermoScientific, EASY-nLC 1000).

[0032] (2) Sample processing

[0033] Sample dissolution: Take an appropriate amount of the crude venom of Agkistrodon acutus and prepare it into 1 µg / µL;

[0034] Reductive alkylation: Take 50 µL (1 µg / µL) sample solution, add 80 µL denaturation buffer (weigh 0.606 g Tris, 8.04 mg EDTA, 5.73 g guanidine hydrochloride, dissolve in 10 mL water, adjust pH to 8.1 with HCl) and 20 µL 1 M DTT, react at 60°C for 30 min; add 40 µL 1 M IA, react for 30 min in the dark;

[0035] Desalting: After washing the 10k ultrafiltration membrane once, add the reduced alkylation sample and centrifuge at 12,000 rpm. Add 400 µL and centrifuge at 12,000 rpm, and repeat 3 times.

[0036] Enzymatic hydrolysis: After desalting, add 100 µL 25 mM NH 4 HCO 3 Dissolve, add 2 µg trypsin and enzymatically digest at 37°C overnight, inactivate at high temperature and freeze-dry after enzymatic digestion;

[0037] Redissolution: Finally, add 500 µL of water to reconstitute and mix, centrifuge at 12,000 rpm for 10 min, and take the supernatant into the injection bottle for LC-MS analysis;

[0038] (3) Experimental conditions

[0039] The chromatographic columns were Thermo Fisher Acclaim PepMap®100 C18 nanoliter columns: 75 μm×15 cm (3 μm, 100Å) and 100 µm ×2 cm (5 µm, 100Å).

[0040] Mobile phase A was 2% acetonitrile in 0.1% formic acid in water; mobile phase B was 98% acetonitrile in 0.1% formic acid in water; injection chamber temperature was 7°C; injection volume was 2 µL. EASY-nLC 1000 nanoliter liquid phase system was used for separation. The flow rate of the nanoliter separation pump was 300 nL / min, and the gradient elution settings are shown in Table 1.

[0041] Mass spectrometry conditions: positive ion mode was used for analysis, spray voltage was 2.0 kV, ion transmission capillary temperature was 275 °C, S-Lens transmission efficiency was set to 60%, and the acquisition range was 350-1,500. Top speed mode was used for parent ion selection, HCD mode was used for fragmentation, and the fragmentation energy NCE was set to 28%.

[0042] Table 1 Nanoliquid phase-high resolution mass spectrometry gradient elution table

[0043]

[0044] (4) Proteome Discoverer database search

[0045] Proteome Discoverer 2.5 was used to search the mass spectrometry data, and the conditions were set as follows: the snake venom phospholipase database in the uniprot website (https: / / www.uniprot.org / ) was selected as the protein sequence database; the protease was trypsin; the maximum missed cleavage site was set to 3; the peptide length was 6-144; the peptide parent ion mass deviation was 10 ppm, and the daughter ion was 0.02 Da; the fragment type was b / y ion; the fixed modification was cysteine ​​methoxylation (+57.021 Da); the variable modification was methionine oxidation (+15.995 Da); peptide verification was performed by setting FDR≤0.01 to control the peptide error rate, and selecting peptides with a credibility attribute of "high".

[0046] 2 Characteristic peptide screening

[0047] The coverage of acid phospholipase A2 (Q7SID6) and alkaline phospholipase A2 (Q1ZY03) in the mass spectrometry results was 81% and 62%, respectively. The detected characteristic peptides were screened, which were required to be specific, unique to the phospholipase A2 of Agkistrodon acutus, of appropriate length, without wrong or missed cleavage sites, without amino acids that are prone to modification or degradation, and with high mass spectrometry response; finally, WDIYPYSWK and DNLDTYNSDTYWR were selected as the characteristic peptides of phospholipase A2 of Agkistrodon acutus, and compared with the database Blast sequence, it was proved that the two peptides were exclusive to phospholipase A2 of Agkistrodon acutus and could be used for species identification.

[0048] The characteristic peptides found in the crude venom of Agkistrodon acutus were verified by high-resolution mass spectrometry, and the corresponding peptides were matched by Proteome Discoverer2.5. The secondary mass spectra are shown in Figure 1-Figure 2 . Example 2

[0049] Species Identification by Triple Quadrupole Mass Spectrometry

[0050] Sample preparation

[0051] Test solution: Prepare the sample to be tested with 25mM ammonium bicarbonate to a concentration of 1 µg / µL; take 100 µL of the sample solution, add 1 µg of trypsin and enzymolyze at 37°C overnight, inactivate at high temperature after enzymolysis; centrifuge at 12000 rpm for 10 min, and take the supernatant to obtain the sample to be tested.

[0052] Blank solution: Take 100 µL of 25 mM ammonium bicarbonate and prepare in the same way.

[0053] 2. Experimental Methods

[0054] Column: Waters ACQUITY UPLC BEH C 18 Chromatographic column (50 mm*2.1 mm, 1.7 µm); mobile phase A: 0.1% formic acid solution, mobile phase B: 0.1% formic acid acetonitrile; gradient elution according to Table 2; column temperature: 40 °C; injection volume: 2 µL; flow rate: 0.3 ml / min.

[0055] Table 2 Gradient elution table

[0056]

[0057] Mass spectrometry conditions: electrospray ion source (ESI), positive ion scan mode, multiple reaction monitoring; vortex ion spray temperature: 500 °C; ionization voltage: 5.5 kV; collision chamber exit voltage: 10 V; entrance voltage (EP) 10 V; qualitative and quantitative ion pair collision energies are shown in Table 3.

[0058] Table 3 Mass-to-charge ratio of characteristic peptides of Agkistrodon acutus phospholipase A2 and mass spectrometry conditions

[0059]

[0060] 2. Experimental results

[0061] Blank solution, crude venom of Agkistrodon acutus and crude venom of Vipera rotundifolia were taken for analysis. Figure 3 ) No interfering peaks appeared at the sample elution position. See the ion chromatogram of the crude venom of Agkistrodon acutus for details. Figure 4The peak time of characteristic peptide 1 was 5.6 min, and the peak time of characteristic peptide 2 was 4.9 min. The corresponding chromatographic peaks of characteristic peptide 1 and characteristic peptide 2 were detected. The above results show that this method can be used for species identification of crude phospholipase A2 of Agkistrodon acutus.

[0062] Ten batches of crude venom of Agkistrodon acutus, ten batches of crude venom of Vipera rotundus, ten batches of crude venom of Agkistrodon acutus and ten batches of crude venom of Agkistrodon acutus were randomly sampled and analyzed by the liquid chromatography-triple quadrupole mass spectrometry described in the present invention. It was found that the characteristic polypeptide 1 and the characteristic polypeptide 2 described in the present invention can 100% identify the crude venom of Agkistrodon acutus.

[0063] The above description only illustrates several embodiments of the present invention, and it cannot be understood as limiting the scope of the present invention. It should be pointed out that other persons in the art may make modifications, substitutions, improvements, etc. without departing from the concept and scope of the present invention, and these all belong to the protection scope of the present invention. Therefore, the scope of the present invention shall be based on the described claims.

Claims

1. A characteristic polypeptide group of phospholipase A2 from Agkistrodon acutus, characterized in that: The characteristic polypeptide group consists of characteristic polypeptide 1 and characteristic polypeptide 2; wherein the amino acid sequence of characteristic polypeptide 1 is WDIYPYSWK, and the amino acid sequence of characteristic polypeptide 2 is DNLDTYNSDTYWR.

2. An application of the characteristic polypeptide group of phospholipase A2 of Agkistrodon acutus according to claim 1, characterized in that the characteristic polypeptide group is used to identify the species source of phospholipase A2; the species category is Agkistrodon acutus, Vipera rotundus, Agkistrodon lanceheadus or Agkistrodon halys; The above identification of species origin adopts the following steps: (1) Dissolve the sample to be tested and inactivate it by enzymatic hydrolysis to prepare the test solution; (2) water was treated with enzymes to prepare a blank solution; (3) injecting the test solution prepared in step (1) and the blank solution prepared in step (2) into a liquid chromatography-mass spectrometer, and performing multiple reaction monitoring in electrospray positive ion mode, using mass-to-charge ratios of m / z 629.30→302.11 and 629.30→680.34 as detection ion pairs of characteristic polypeptide 1, and using mass-to-charge ratios of m / z 831.86→230.08 and 831.86→941.41 as detection ion pairs of characteristic polypeptide 2, so as to determine whether the sample to be tested contains characteristic polypeptide 1 and characteristic polypeptide 2 in the characteristic polypeptide of phospholipase A2 of Agkistrodon acutus; (4) If both characteristic polypeptide 1 and characteristic polypeptide 2 are detected, it proves that the sample to be tested contains phospholipase A2 and is derived from Agkistrodon acutus; otherwise, it proves that the sample to be tested does not contain phospholipase A2 from Agkistrodon acutus; In the liquid chromatography-mass spectrometer of step (3), the liquid phase and mass spectrometry detection conditions are: Waters ACQUITY UPLC BEH C 18 Chromatographic column 50mm*2.1mm, 1.7μm; mobile phase A: 0.1% formic acid solution, mobile phase B: 0.1% formic acid acetonitrile; column temperature: 40℃; injection volume: 2μL; flow rate: 0.3ml / min; gradient elution according to the table below: In the liquid chromatography-mass spectrometer of step (3), the mass spectrometry conditions are: Electrospray ion source (ESI), positive ion scan mode, multiple reaction monitoring; vortex ion spray temperature: 500 ° C; ionization voltage: 5.5 kV; collision chamber exit voltage: 10 V; entrance voltage (EP) 10 V; qualitative and quantitative ion pair collision energies are shown in the following table: The specific operation of step (1) is: ① Dissolution of the sample to be tested: The sample to be tested is prepared with 25mM ammonium bicarbonate to a concentration of 1μg / μL; ② Enzymatic hydrolysis: Take 100 μL of the sample dissolved in step ①, add 1 μg trypsin and hydrolyze at 37°C overnight, and inactivate at high temperature after the hydrolysis is completed; ③ Centrifugation: Finally, take the sample inactivated by enzymatic hydrolysis in step ②, centrifuge it at 12000rpm for 10min, and take the supernatant to obtain the sample to be tested.